Transient cutaneous manifestations after administration of Pfizer-BioNTech COVID-19 Vaccine: an Italian single-centre case series.
作者信息
Corbeddu M, Diociaiuti A, Vinci M R, Santoro A, Camisa V, Zaffina S, El Hachem M
机构信息
Dermatology Unit and Genodermatosis Unit, Genetics and Rare Diseases Research Division, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Health Directorate and Occupational Medicine, Health Technology Assessment and Safety Research Unit, Clinical-Technological Innovations Research Area, Bambino Gesù Children's Hospital, IRCSS, Rome, Italy.
出版信息
J Eur Acad Dermatol Venereol. 2021 Aug;35(8):e483-e485. doi: 10.1111/jdv.17268. Epub 2021 Apr 24.
Abstract
摘要
相似文献
1
Transient cutaneous manifestations after administration of Pfizer-BioNTech COVID-19 Vaccine: an Italian single-centre case series.辉瑞-生物科技公司新冠疫苗接种后的短暂皮肤表现：一项意大利单中心病例系列研究
J Eur Acad Dermatol Venereol. 2021 Aug;35(8):e483-e485. doi: 10.1111/jdv.17268. Epub 2021 Apr 24.
2
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.COVID-19 疫苗：辉瑞/生物科技和 Moderna 疫苗的生物学、药理学特征和不良反应比较。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.
3
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12-15 Years - United States, May 2021.免疫实践咨询委员会关于辉瑞-BioNTech COVID-19 疫苗在 12-15 岁青少年中使用的临时建议-美国，2021 年 5 月。
MMWR Morb Mortal Wkly Rep. 2021 May 21;70(20):749-752. doi: 10.15585/mmwr.mm7020e1.
4
Blood pressure increase after Pfizer/BioNTech SARS-CoV-2 vaccine.辉瑞/生物科技公司的新冠病毒疫苗接种后血压升高。
Eur J Intern Med. 2021 Aug;90:111-113. doi: 10.1016/j.ejim.2021.06.013. Epub 2021 Jun 16.
5
Morbilliform rash after administration of Pfizer-BioNTech COVID-19 mRNA vaccine.接种辉瑞-生物科技公司新冠mRNA疫苗后出现麻疹样皮疹。
Dermatol Online J. 2021 Jan 15;27(1):13030/qt4xs486zg.
6
[Eczematiform eruption after Pfizer-BioNTech COVID-19 vaccine].[辉瑞-生物科技公司新冠疫苗接种后出现的湿疹样皮疹]
Therapie. 2021 Jul-Aug;76(4):364-365. doi: 10.1016/j.therap.2021.04.012. Epub 2021 Apr 29.
7
An Additional Case of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine.辉瑞-BioNTech新冠疫苗接种后发生的又一例微小病变病病例。
Am J Kidney Dis. 2021 Aug;78(2):312. doi: 10.1053/j.ajkd.2021.05.003. Epub 2021 May 13.
8
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020.免疫实践咨询委员会关于使用辉瑞-BioNTech COVID-19 疫苗的临时建议-美国，2020 年 12 月。
MMWR Morb Mortal Wkly Rep. 2020 Dec 18;69(50):1922-1924. doi: 10.15585/mmwr.mm6950e2.
9
The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 ≥7 days after the 2nd dose.BNT162b2（辉瑞/生物科技）疫苗在第 2 剂接种后 ≥7 天对 COVID-19 的有效率为 95%。
Ann Intern Med. 2021 Feb;174(2):JC15. doi: 10.7326/ACPJ202102160-015. Epub 2021 Feb 2.
10
Persistent maculopapular rash after the first dose of Pfizer-BioNTech COVID-19 vaccine.接种第一剂辉瑞-生物科技公司新冠疫苗后出现持续性斑丘疹皮疹。
J Eur Acad Dermatol Venereol. 2021 Jul;35(7):e423-e425. doi: 10.1111/jdv.17248. Epub 2021 Apr 8.
引用本文的文献
1
Management of coronavirus disease 2019 vaccine-induced cutaneous complications: A comprehensive literature review.2019冠状病毒病疫苗诱导的皮肤并发症的管理：一项全面的文献综述。
J Family Community Med. 2023 Jul-Sep;30(3):161-170. doi: 10.4103/jfcm.jfcm_3_23. Epub 2023 Jul 24.
2
The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature.COVID-19 疫苗接种对炎症性皮肤疾病和其他皮肤疾病的影响：已发表文献综述。
Viruses. 2023 Jun 23;15(7):1423. doi: 10.3390/v15071423.
3
Global incidence pattern and factors associated with common cutaneous reactions related to COVID-19 vaccination of 2.55 million participants in real-world settings: A systematic review and meta-analysis.全球真实环境下 255 万参与者中与 COVID-19 疫苗接种相关的常见皮肤反应的发病模式及相关因素：系统评价和荟萃分析。
J Glob Health. 2023 Feb 10;13:06008. doi: 10.7189/jogh.13.06008.
4
Effect of COVID-19 (SARS-CoV-2) Vaccination on Patients with Atopic Dermatitis Treated with Dupilumab: A Multicenter, Observational Study.新型冠状病毒肺炎（SARS-CoV-2）疫苗接种对接受度普利尤单抗治疗的特应性皮炎患者的影响：一项多中心观察性研究。
Ann Dermatol. 2023 Feb;35(1):38-45. doi: 10.5021/ad.22.118.
5
Skin manifestations following anti-COVID-19 vaccination: A multicentricstudy from Turkey.接种新冠疫苗后的皮肤表现：来自土耳其的一项多中心研究。
J Cosmet Dermatol. 2023 Feb;22(2):354-363. doi: 10.1111/jocd.15570. Epub 2022 Dec 27.
6
SARS-CoV-2 Vaccination and Chilblain-like Lesions: What Do We Know so Far?新型冠状病毒2型疫苗接种与冻疮样病变：我们目前了解到了什么？
Dermatol Pract Concept. 2022 Oct 1;12(4):e2022170. doi: 10.5826/dpc.1204a170. eCollection 2022 Nov.
7
Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature.新冠疫苗接种后的皮肤反应：当前文献综述
Clin Cosmet Investig Dermatol. 2022 Nov 6;15:2369-2382. doi: 10.2147/CCID.S388245. eCollection 2022.
8
Viruses, Variants, and Vaccines: How COVID-19 Has Changed the Way We Look at Skin.病毒、变种与疫苗：新冠疫情如何改变我们对皮肤的看法。
Curr Dermatol Rep. 2022;11(4):289-312. doi: 10.1007/s13671-022-00370-9. Epub 2022 Oct 17.
9
Skin reaction to COVID-19 vaccine: A report of 4 cases.新型冠状病毒肺炎疫苗的皮肤反应：4例报告
Dermatol Reports. 2022 Jul 12;14(3):9376. doi: 10.4081/dr.2022.9376. eCollection 2022 Sep 14.
10
Spectrum of Mucocutaneous Reactions to COVID-19 Vaccination: A Report from a Web-Based Study from India.新型冠状病毒肺炎疫苗接种的皮肤黏膜反应谱：来自印度一项基于网络研究的报告
Indian J Dermatol. 2022 Mar-Apr;67(2):115-120. doi: 10.4103/ijd.ijd_893_21.
Zotero 插件